Cite
da Rocha Lino A, Abrahão CM, Brandão RM, et al. Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis. J Gastrointest Oncol. 2015;6(5):511-5doi: 10.3978/j.issn.2078-6891.2015.041.
da Rocha Lino, A., Abrahão, C. M., Brandão, R. M., Gomes, J. R., Ferrian, A. M., Machado, M. C., Buzaid, A. C., Maluf, F. C., & Peixoto, R. D. (2015). Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis. Journal of gastrointestinal oncology, 6(5), 511-5. https://doi.org/10.3978/j.issn.2078-6891.2015.041
da Rocha Lino, Aline, et al. "Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis." Journal of gastrointestinal oncology vol. 6,5 (2015): 511-5. doi: https://doi.org/10.3978/j.issn.2078-6891.2015.041
da Rocha Lino A, Abrahão CM, Brandão RM, Gomes JR, Ferrian AM, Machado MC, Buzaid AC, Maluf FC, Peixoto RD. Role of gemcitabine as second-line therapy after progression on FOLFIRINOX in advanced pancreatic cancer: a retrospective analysis. J Gastrointest Oncol. 2015 Oct;6(5):511-5. doi: 10.3978/j.issn.2078-6891.2015.041. PMID: 26487945; PMCID: PMC4570924.
Copy
Download .nbib